In view of the promising efficacy of anti-PD-1 therapy in several cancer patients, we examined the expression of the checkpoint molecule PD-1 on all distinct T subsets and found that the PD-1 expression on T-cell subsets, particularly CD8+ T cells, between cancer tissues and adjacent tissues was basically comparable (Figure 2I). This evidence concerns the gene CD8A and cancer.